Ionis Pharmaceuticals(GB:0JDI)
$28.60+1.00 (+3.63%)
GB:0JDI
Ionis Pharmaceuticals ownership
$28.60
At close:+1.00 (+3.63%)
Ionis Pharmaceuticals (0JDI) Ownership - Who Owns Ionis Pharmaceuticals?
0 Followers
Ionis Pharmaceuticals (0JDI) Ownership Overview
- 0.74% Insiders
- 46.30% Mutual Funds
- 31.31% Other Institutional Investors
- 16.75% ETFs
- 4.89% Public Companies and Individual Investors
The ownership structure of Ionis Pharmaceuticals (GB:0JDI) stock is a mix of institutional, retail, and individual investors. Approximately 94.37% of the company’s stock is owned by Institutional Investors, 0.74% is owned by Insiders, and 4.89% is owned by Public Companies and Individual Investors.
The ownership structure of Ionis Pharmaceuticals (GB:0JDI) stock is a mix of institutional, retail, and individual investors. Approximately 94.37% of the company’s stock is owned by Institutional Investors, 0.74% is owned by Insiders, and 4.89% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 12, 2026 | Michael R. Hayden | $148,200 | |
| Jul 30, 2026 | Michael R. Hayden | $1,058,700 | |
| Feb 03, 2026 | Frank C. Bennett | $7,055,489 | |
| Feb 01, 2026 | Eric Swayze | $512,424 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | $600,919 | |
| Dec 31, 2025 | Gilder Gagnon Howe & Co Llc. | $1,524,845 | |
| Dec 31, 2025 | Bridgewater Associates, Lp | $5,356,221 | |
| Dec 31, 2025 | Fisher Asset Management Llc | $11,203,162 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 13,390,177 | Institution | 8.04% | 382,959,062 |
| BlackRock, Inc. | 13,192,834 | Institution | 7.92% | 377,315,052 |
| Fidelity Mt. Vernon Street Trust | 12,889,618 | Institution | 7.74% | 368,643,075 |
| Vanguard Index Funds | 12,557,124 | Institution | 7.54% | 359,133,746 |
| Growth Fund Of America | 7,668,655 | Institution | 4.60% | 219,323,533 |
| Vanguard Specialized Funds | 6,212,640 | Institution | 3.73% | 177,681,504 |
| Smallcap World Fund Inc | 5,259,919 | Institution | 3.16% | 150,433,683 |
| Ishares | 5,145,135 | Institution | 3.09% | 147,150,861 |
| New Economy Fund | 4,868,802 | Institution | 2.92% | 139,247,737 |
| Ivy Funds | 3,279,894 | Institution | 1.97% | 93,804,968 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust | 12,889,618 | Institution | 7.74% | 368,643,075 |
| Vanguard Index Funds | 12,557,124 | Institution | 7.54% | 359,133,746 |
| Growth Fund Of America | 7,668,655 | Institution | 4.60% | 219,323,533 |
| Vanguard Specialized Funds | 6,212,640 | Institution | 3.73% | 177,681,504 |
| Smallcap World Fund Inc | 5,259,919 | Institution | 3.16% | 150,433,683 |
| New Economy Fund | 4,868,802 | Institution | 2.92% | 139,247,737 |
| Ivy Funds | 3,279,894 | Institution | 1.97% | 93,804,968 |
| T. Rowe Price Mid-cap Growth Fund, Inc. | 1,998,674 | Institution | 1.20% | 57,162,076 |
| Tweedy, Browne Fund Inc. | 1,963,162 | Institution | 1.18% | 56,146,433 |
| Legg Mason Partners Investment Trust | 1,655,237 | Institution | 0.99% | 47,339,778 |
FAQ
Who Owns Ionis Pharmaceuticals (GB:0JDI)?
According to the latest TipRanks data, approximately 94.37% of the company's stock is held by institutional investors, 0.74% is held by insiders, and 4.89% is held by public companies and individual investors.
What percentage of Ionis Pharmaceuticals (GB:0JDI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 94.37% of Ionis Pharmaceuticals (GB:0JDI) stock is held by institutional investors: 46.30% by mutual funds, 16.75% by ETFs and 31.31% by other institutional investors.
What percentage of Ionis Pharmaceuticals (GB:0JDI) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.89% of Ionis Pharmaceuticals (GB:0JDI) stock is held by public companies and individual investors.
Who owns the most shares of Ionis Pharmaceuticals (GB:0JDI)?
Vanguard owns the most shares of Ionis Pharmaceuticals (GB:0JDI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

